Grafting Myoblasts Genetically Engineered to Produce BDNF in Rats Parkinson Disease Models

Cheng He
1999-01-01
Abstract:Objective To observe the role of genetically engineered myoblast in the treatment of rat Parkinson disease models Methods Genetically modified myoblasts to produce brain derived neurotrophic factors (BDNF) were established and grafted into the corpora striata of Parkinson disease modelsin rats. The behavior and pathological changes were observed and the Dopamine contents in the corbora striata were measured with high performance liquid chromatography (HPLC). Results The intracranial graft of genetically engineered myoblasts can promote the survival of TH positive neurons in the nigra of Parkinson's rat and the content of Dopamine in the striatum were increased significantly. The rotation behavior improved 50% after the transplantation. Conclusion It is suggested that BDNF secreting myoblasts can promote the survival of the neuron and provide a new and effective method for the treatment of Parkinson disease.
What problem does this paper attempt to address?